Variation of the polymorphic region X of the protein A gene during persistent airway infection of cystic fibrosis patients reflects two independent mechanisms of genetic change in Staphylococcus aureus.

Comments on this publication

ResearchGate members can add comments. Sign up now and post your comment!

Similar publications

• In vitro activity of fusidic acid (CEM-102, sodium fusidate) against Staphylococcus aureus isolates from cystic fibrosis patients and its effect on the activities of tobramycin and amikacin against Pseudomonas aeruginosa and Burkholderia cepacia.

  Authors: Pamela McGhee, Catherine Clark, Kim Credito, Linda Beachel, Glenn A Pankuch, Peter C Appelbaum, Klaudia Kosowska-Shick

  Antimicrobial agents and chemotherapy. 55(5):2417-9.

• SCCmec Type IV, PVL-Negative, Methicillin-Resistant Staphylococcus aureus in Cystic Fibrosis Patients from Brazil.

  Authors: Marcelo J Mimica, Eitan N Berezin, Neiva Damaceno, Rozane B Carvalho

  Current microbiology. 62(2):388-90.

• Adaptive evolution of Staphylococcus aureus during chronic endobronchial infection of a cystic fibrosis patient.

  Authors: Paul R McAdam, Anne Holmes, Kate E Templeton, J Ross Fitzgerald

  PloS one. 6(9):e24301.

Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.